REVIEWS |
A.F. Verbovoy, N.I. Verbovaya, L.A. Sharonova
Hypothyroidism is an untimely diagnosed disease
|
12-21 |
A.E. Bagriy, E.S. Mikhailichenko, A.V. Prikolota, K.E. Mogilevskaya
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic
|
22-27 |
A.I. Listratov, O.D. Ostroumova, N.L. Lyakhova
Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 2
|
28-34 |
|
M.G. Pavlova
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
|
36-40 |
ORIGINAL ARTICLES |
M.B. Antsiferov, N.A. Demidov, T.I. Safronova, O.A. Mishra
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
|
41-46 |
A.E. Bagriy, O.A. Prikolota, A.V. Prikolota, E.S. Mikhailichenko, I.A. Golodnikov, O.N. Bagriy, K.A. Kotova
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
|
47-52 |
I.A. Ilovayskaya, P.A. Zakharova, E.D. Metlushko
Monitoring of patients with acromegaly in the real-life clinical practice settings
|
53-59 |
D.I. Sadykova, E.S. Slastnikova, L.F. Galimova, T.P. Makarova, A.A. Kamalova, Yu.S. Melnikova, R.F. Rakhmaeva, M.A. Petrova, A.A. Mustafaeva, G.G. Semenova
Endothelial function in children with familial hypercholesterolemia
|
60-65 |
N.A. Petunina, N.S. Martirosyan, F.V. Valeeva
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
|
66-75 |
N.A. Korobkov, N.V. Bakulina, G.G. Rodionov, E.A. Kolobova
Optimization of antibiotic prophylaxis of deep surgical site infection during caesarean section in obese pregnant women
|
76-80 |
|
M.B. Antsiferov, O.M. Koteshkova, O.V. Dukhareva, N.A. Demidov, M.S. Novikova
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
|
81-88 |
I.A. Kurnikova, Sh.G. Gulova, N.O. Danilina, A.S. Klimenko, D.D. Chentsova
Effective treatment of exogenous-constitutional obesity in a young patient: a description of a clinical case
|
89-94 |
N.A. Strebkova, A.L. Kalinin
Three-phase course of central diabetes insipidus in a child after removal of craniopharyngioma: a clinical case
|
96-98 |
A.I. Semenova, S.A. Protsenko, G.M. Teletaeva, D.Kh. Latipova, A.V. Novik
Possibilities of the combination of avelumab and axitinib in the first line in patients with advanced renal cell carcinoma
|
99-105 |
V.F. Semiglazov, P.V. Krivorotko, A.V. Komyakhov, T.Yu. Semiglazova, L.P. Gigolaeva, T.T. Tabagua, M.D. Kazantseva, A.P. Tergoeva, D.G. Ulrikh, M.V. Chervyak, V.V. Klimenko, N.S. Amirov, E.K. Zhiltsova, V.V. Semiglazov
The role of alpelisib in the treatment of PIK3CA – a mutated breast cancer
|
106-110 |
V.F. Semiglazov, P.V. Krivorotko, T.Yu. Semiglazova, A.V. Komyakhov, T.T. Tabagua, M.D. Kazantseva, E.K. Zhiltsova, D.G. Ulrikh, M.V. Chervyak, A.P. Tergoeva, V.V. Klimenko, V.V. Semiglazov
Ixabepilone in the treatment of breast cancer
|
112-117 |
ORIGINAL ARTICLES |
E.O. Golubenko, M.I. Savelyeva, Zh.A. Sozaeva, I.V. Poddubnaya, V.V. Korennaya
Clinical significance of genetic polymorphism of tamoxifen metabolic enzymes and transporters in breast cancer: results of a population-based cohort study
|
118-126 |
E.E. Osipyan, A.A. Makhova, V.N. Drozdov, E.V. Shikh
Clinical significance of increased hepcidin expression in patients with anemia of chronic diseases with iron deficiency
|
127-131 |
A.S. Mochalova
Evaluation of immune response checkpoint dynamics in patients with lung cancer receiving immune therapy
|
132-135 |
T.I. Bonkalo, E.V. Plekhanova, E.D. Bakulina, A.N. Vakulenko
Mechanisms of professional-identification destructions in students with disabilities in the process of their study at the university
|
136-140 |
|
E.A. Moskvina, D.R. Naskhletashvili, A.Kh. Bekyashev, K.E. Roshchina
Regorafenib in the treatment of recurrent glioblastoma: a clinical case
|
141-146 |
G.A. Khakimov, G.G. Khakimova, Zh.B. Sadullaev, A.M. Khakimov, Kh.U. Musurmonov, Kh.N. Abdullaeva, O.O. Rasulov
Successful surgical treatment of mediastinal germ cell tumor against the background of chemoresistance
|
147-151 |